SEC Form 4 · accession 0001209191-18-058782
CONCERT PHARMACEUTICALS, INC. · CNCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas G Auchincloss
Director
Period of report
Nov 14, 2018
Accepted (ET)
Nov 15, 2018 · 5:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367920
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 14, 2018 | P | 1,000 | $11.9314 | A | 3,000 | D |
Table II — derivative securities
No Table II lines on this filing.